Publikation: Development and characterization of improved beta-lactone-based anti-virulence drugs targeting ClpP
Lade...
Dateien
Zu diesem Dokument gibt es keine Dateien.
Datum
2012
Autor:innen
Herausgeber:innen
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
URI (zitierfähiger Link)
DOI (zitierfähiger Link)
Internationale Patentnummer
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Sammlungen
Core Facility der Universität Konstanz
Titel in einer weiteren Sprache
Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published
Erschienen in
Bioorganic & Medicinal Chemistry. 2012, 20(2), pp. 583-591. ISSN 0968-0896. eISSN 1464-3391. Available under: doi: 10.1016/j.bmc.2011.07.047
Zusammenfassung
Here, we report the synthesis and in depth characterization of a second generation β-lactone derived virulence inhibitors. Based on initial results that emphasized the intriguing possibility to disarm bacteria in their virulence the present study develops this concept further and analyses the potential of this strategy for drug development. We were able to expand the collection of bioactive compounds via an efficient synthetic route. Testing of all compounds revealed several hits with anti-virulence activity. Moreover, we demonstrated that these molecules act solely by reducing virulence but not killing bacteria which is an important prerequisite for preserving the useful microbiome. Finally, incubation of lactones with eukaryotic cell lines indicated a tolerable cytotoxicity which is essential for entering animal studies.
Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
540 Chemie
Schlagwörter
Konferenz
Rezension
undefined / . - undefined, undefined
Zitieren
ISO 690
ZEILER, Evelyn, Vadim S. KOROTKOV, Katrin LORENZ-BAATH, Thomas BÖTTCHER, Stephan A. SIEBER, 2012. Development and characterization of improved beta-lactone-based anti-virulence drugs targeting ClpP. In: Bioorganic & Medicinal Chemistry. 2012, 20(2), pp. 583-591. ISSN 0968-0896. eISSN 1464-3391. Available under: doi: 10.1016/j.bmc.2011.07.047BibTex
@article{Zeiler2012-01-15Devel-28436,
year={2012},
doi={10.1016/j.bmc.2011.07.047},
title={Development and characterization of improved beta-lactone-based anti-virulence drugs targeting ClpP},
number={2},
volume={20},
issn={0968-0896},
journal={Bioorganic & Medicinal Chemistry},
pages={583--591},
author={Zeiler, Evelyn and Korotkov, Vadim S. and Lorenz-Baath, Katrin and Böttcher, Thomas and Sieber, Stephan A.}
}RDF
<rdf:RDF
xmlns:dcterms="http://purl.org/dc/terms/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
xmlns:bibo="http://purl.org/ontology/bibo/"
xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
xmlns:foaf="http://xmlns.com/foaf/0.1/"
xmlns:void="http://rdfs.org/ns/void#"
xmlns:xsd="http://www.w3.org/2001/XMLSchema#" >
<rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28436">
<bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/28436"/>
<dc:contributor>Zeiler, Evelyn</dc:contributor>
<dc:contributor>Korotkov, Vadim S.</dc:contributor>
<dc:creator>Lorenz-Baath, Katrin</dc:creator>
<dc:creator>Sieber, Stephan A.</dc:creator>
<dcterms:title>Development and characterization of improved beta-lactone-based anti-virulence drugs targeting ClpP</dcterms:title>
<dc:contributor>Sieber, Stephan A.</dc:contributor>
<dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/29"/>
<dc:creator>Böttcher, Thomas</dc:creator>
<dc:contributor>Böttcher, Thomas</dc:contributor>
<void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
<dcterms:issued>2012-01-15</dcterms:issued>
<dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/29"/>
<dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
<foaf:homepage rdf:resource="http://localhost:8080/"/>
<dc:creator>Korotkov, Vadim S.</dc:creator>
<dcterms:bibliographicCitation>Bioorganic & Medicinal Chemistry ; 20 (2012), 2. - S. 583-591</dcterms:bibliographicCitation>
<dc:rights>terms-of-use</dc:rights>
<dc:creator>Zeiler, Evelyn</dc:creator>
<dc:language>eng</dc:language>
<dc:contributor>Lorenz-Baath, Katrin</dc:contributor>
<dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2014-07-18T08:32:15Z</dcterms:available>
<dcterms:abstract xml:lang="eng">Here, we report the synthesis and in depth characterization of a second generation β-lactone derived virulence inhibitors. Based on initial results that emphasized the intriguing possibility to disarm bacteria in their virulence the present study develops this concept further and analyses the potential of this strategy for drug development. We were able to expand the collection of bioactive compounds via an efficient synthetic route. Testing of all compounds revealed several hits with anti-virulence activity. Moreover, we demonstrated that these molecules act solely by reducing virulence but not killing bacteria which is an important prerequisite for preserving the useful microbiome. Finally, incubation of lactones with eukaryotic cell lines indicated a tolerable cytotoxicity which is essential for entering animal studies.</dcterms:abstract>
<dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2014-07-18T08:32:15Z</dc:date>
</rdf:Description>
</rdf:RDF>Interner Vermerk
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Prüfungsdatum der Dissertation
Finanzierungsart
Kommentar zur Publikation
Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Nein
